20-07-2026 15:43 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Aurobindo Pharma Ltd.
Change Company   
BSE Code 524804
ISIN Demat INE406A01037
Book Value 394.82
NSE Code AUROPHARMA
Dividend Yield % 0.26
Market Cap 900811.63
P/E 37.30
EPS 41.97
Face Value 1  
10-Jul-2026 Aurobindo Pharma’s arm incorporates subsidiary in...
30-Jun-2026 Aurobindo Pharma’s arm completes acquisition of L...
30-Jun-2026 Aurobindo Pharma gains as its arm completes acqui...
29-Jun-2026 USFDA completes inspection at Aurobindo Pharma’s ...
22-Jun-2026 Aurobindo Pharma informs about press release
22-Jun-2026 Aurobindo Pharma moves up as its arm gets US FTC’...
20-Jun-2026 USFDA completes PAI at Aurobindo Pharma’s arm’s A...
20-Jun-2026 Aurobindo Pharma informs about updates
19-Jun-2026 Aurobindo Pharma’s arm gets US FTC’s nod for acqu...
19-Jun-2026 Aurobindo Pharma informs about disclosure
19-Jun-2026 Aurobindo Pharma jumps as its arm gets US FTC’s n...
13-Jun-2026 USFDA inspects Aurobindo Pharma’s arm’s Eugia Uni...
05-Jun-2026 Aurobindo Pharma gets USFDA’s final nod for Tofac...
05-Jun-2026 Aurobindo Pharma gains on getting USFDA’s final n...
04-Jun-2026 Aurobindo Pharma inaugurates biologics contract m...
Page 1 of 5
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code | Reasearch Analyst Certificate
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.